Replenix BP Acne
- Product NDC
- 51326-841
- 11-digit product format
- 513260841
- Labeler code
- 51326
- Product ID
- 51326-841_9b7bae4b-461d-4d02-89d2-feb8ee6606df
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Benzoyl Peroxide
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Topiderm, Inc.
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-05-13
- Substance
- BENZOYL PEROXIDE
- Active strength
- 100 mg/g
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Replenix BP Acne
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BENZOYL PEROXIDE | 100 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | W9WZN9A0GM |
| Rxcui | 486131 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51326-841-20 | Replenix BP Acne | 57 g in 1 BOTTLE | GEL | 57 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51326-841 | REPLENIX BP ACNE (BENZOYL PEROXIDE) GEL [TOPIDERM, INC.] | 1 | Current NDC, 1 package rows | 20240731_f449e020-a4d8-4a1b-82eb-4dc59e99b8d4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51326-841-20 | 51326084120 | 57 g in 1 BOTTLE (51326-841-20) | 57 g | 2021-05-13 | No | No | Current |